A first-in-human phase Ia/b, open-label, multicenter study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers Meeting Abstract
| Authors: | Harding, J. J.; Hofheinz, R. D.; Elez, E.; Kuboki, Y.; Rasco, D. W.; Cecchini, M.; Shen, L.; Dowling, E.; Archuadze, S.; de Pereira, B. A.; Pant, S. |
| Abstract Title: | A first-in-human phase Ia/b, open-label, multicenter study of the TRAILR2 agonist BI 905711 in patients (pts) with advanced gastrointestinal (GI) cancers |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900217 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.TPS222 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS222 -- Meeting was conducted online as well as in person -- Source: Wos |
